CT Healthcare Trust PLC
16 September 2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
CT Healthcare Trust plc (the "Company")
Completion of Quarterly Tender Offer
16 September 2026
Further to the quarterly tender offer launched by the Company on 6 August 2026 (the "Tender Offer") for up to 15 per cent. of the Company's issued Shares (excluding any Shares held in treasury), the Company announces that it has acquired 3,885,283 ordinary redeemable shares of £0.01 each in the capital of the Company (the "Shares") pursuant to the Tender Offer. All Shares repurchased by the Company will be held in treasury.
Payment to shareholders of the Tender Offer consideration will be made as soon as practicable and by no later than 10 Business Days following the date of this announcement.
Following the above transaction, the Company holds 272,780,661 of its Shares in treasury and has 42,371,648 Shares in issue (excluding treasury shares).
For further information, please contact:
|
CT Healthcare Trust plc |
Enquires through JP Morgan Cazenove |
|
Sarah MacAulay, Chairman |
|
|
Columbia Threadneedle Investments |
+44 (0) 207 464 5000 |
|
Marrack Tonkin, Head of Investment Trusts |
|
|
JP Morgan Cazenove |
+44 (0) 20 3493 8000 |
|
William Simmonds / Rupert Budge |
|
|
Company Secretary Scott McEllen
|
+44 (0) 131 573 8372 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.